These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 8813442
21. Optimizing cardiac energy metabolism: how can fatty acid and carbohydrate metabolism be manipulated? Lopaschuk GD. Coron Artery Dis; 2001 Feb; 12 Suppl 1():S8-11. PubMed ID: 11286307 [Abstract] [Full Text] [Related]
22. Chronic heart failure and type 2 diabetes mellitus: The last battle? Kearney MT. Diab Vasc Dis Res; 2015 Jul; 12(4):226-7. PubMed ID: 26099813 [No Abstract] [Full Text] [Related]
26. Alterations in myocardial metabolism in the diabetic myocardium. Lazar HL. Semin Thorac Cardiovasc Surg; 2006 Jul; 18(4):289-92. PubMed ID: 17395024 [Abstract] [Full Text] [Related]
27. Effects of activation of endocannabinoid system on myocardial metabolism. Polak A, Harasim E, Chabowski A. Postepy Hig Med Dosw (Online); 2016 May 21; 70(0):542-55. PubMed ID: 27333924 [Abstract] [Full Text] [Related]
29. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure. Fukushima A, Lopaschuk GD. Biochim Biophys Acta; 2016 Dec 21; 1862(12):2211-2220. PubMed ID: 27479696 [Abstract] [Full Text] [Related]
30. Myocardial metabolism of glucose, lactic acid, amino acids and fatty acids in healthy human individuals at rest and at different work loads. CARLSTEN A, HALLGREN B, JAGENBURG R, SVANBORG A, WERKO L. Scand J Clin Lab Invest; 1961 Dec 21; 13():418-28. PubMed ID: 13876667 [No Abstract] [Full Text] [Related]
33. Protective mechanisms of mitochondria and heart function in diabetes. Aon MA, Tocchetti CG, Bhatt N, Paolocci N, Cortassa S. Antioxid Redox Signal; 2015 Jun 10; 22(17):1563-86. PubMed ID: 25674814 [Abstract] [Full Text] [Related]
34. Metabolism in non-ischemic myocardium during coronary artery occlusion and reperfusion. Buxton DB, Mody FV, Krivokapich J, Schelbert HR. J Mol Cell Cardiol; 1993 Jun 10; 25(6):667-81. PubMed ID: 8411193 [Abstract] [Full Text] [Related]
35. Glucose and fatty acid metabolism in the isolated working mouse heart. Belke DD, Larsen TS, Lopaschuk GD, Severson DL. Am J Physiol; 1999 Oct 10; 277(4):R1210-7. PubMed ID: 10516264 [Abstract] [Full Text] [Related]
37. Reversible myocardial dysfunction in sepsis and ischemia. Kan H, Failinger CF, Fang Q, Finkel MS. Crit Care Med; 2005 Dec 10; 33(12):2845-7. PubMed ID: 16352971 [No Abstract] [Full Text] [Related]
38. Assessment of myocardial metabolic flexibility and work efficiency in human type 2 diabetes using 16-[18F]fluoro-4-thiapalmitate, a novel PET fatty acid tracer. Mather KJ, Hutchins GD, Perry K, Territo W, Chisholm R, Acton A, Glick-Wilson B, Considine RV, Moberly S, DeGrado TR. Am J Physiol Endocrinol Metab; 2016 Mar 15; 310(6):E452-60. PubMed ID: 26732686 [Abstract] [Full Text] [Related]
39. Impact of 1 wk of diabetes on the regulation of myocardial carbohydrate and fatty acid oxidation. Chatham JC, Gao ZP, Forder JR. Am J Physiol; 1999 Aug 15; 277(2):E342-51. PubMed ID: 10444431 [Abstract] [Full Text] [Related]
40. SIGNIFICANCE OF RECENT ADVANCES IN LIPID AND CARBOHYDRATE METABOLISM. VANDUYNE CM. J Okla State Med Assoc; 1965 Jan 15; 58():17-25. PubMed ID: 14256285 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]